Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406

International Journal of Radiation Oncology Biology Physics

Volumn 46, Issue 2, 2000, Pages 391-402

  Michalski, Jeff M ^a   Purdy, James A ^b   Winter, Kathryn ^m   Roach III, Mack ^c   Vijayakumar, Srinivasan ^d   Sandler, Howard M ^e   Markoe, Arnold M ^f   Ritter, Mark A ^g   Russell, Kenneth J ^h   Sailer, Scott ⁱ   Harms, William B ^b   Perez, Carlos A ^a   Wilder, Richard B ^j   Hanks, Gerald E ^k   Cox, James D ^l  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

^f UNIVERSITY OF MIAMI   (United States)

^g UNIVERSITY OF WISCONSIN MADISON   (United States)

^h UNIVERSITY OF WASHINGTON   (United States)

ⁱ UNIVERSITY OF NORTH CAROLINA   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k FOX CHASE CANCER CENTER   (United States)

^l UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^m NONE

more..

Author keywords

3D conformal radiation therapy; Prostate cancer; Quality assurance; Radiation toxicity

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; GASTROINTESTINAL TOXICITY; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; RADIATION DOSE; RADIATION SICKNESS; URINARY TRACT DISEASE;

EID: 0033959048     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(99)00443-5     Document Type: Article

References (36)

1. Hanks G.E., Martz K.L., Diamond J.J. The effect of dose on local control of prostate cancer. Int J Radiat Oncol Biol Phys. 15:1988;1299-1305.
2. Perez C.A., Pilepich M.V., Zivnuska F. Tumor control in definitive irradiation of localized carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 12:1986;523-531.
3. Hanks G.E., Schultheiss T.E., Hanlon A.L., et al. Optimization of conformal radiation treatment of prostate cancer Report of a dose escalation study . Int J Radiat Oncol Biol Phys. 37:1997;543-550.
4. Sandler H.M., McLaughlin W.P., Ten Haken R.K., et al. Three dimensional conformal radiotherapy for the treatment of prostate cancer Low risk of chronic rectal morbidity observed in a large series of patients . Int J Radiat Oncol Biol Phys. 33:1995;797-801.
5. Leibel S.A., Heimann R., Kutcher G.J., et al. Three-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate Preliminary results of a phase I dose-escalation study . Int J Radiat Oncol Biol Phys. 28:1993;55-65.
6. 125I implantation . Int J Radiol Oncol Biol Phys. 21:1991;537-547.
7. Schultheiss T.E., Lee W.R., Hunt M.A., et al. Late GI and GU complications in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 37:1997;3-11.
8. Pollack A., Zagars G.K., Starkschall G., et al. Conventional vs. conformal radiotherapy for prostate cancer Preliminary results of dosimetry and acute toxicity . Int J Radiat Oncol Biol Phys. 34:1996;555-564.
9. Zelefsky M.J., Leibel S.A., Gaudin P.B., et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys. 41:1998;491-500.
10. Pollack A., Zagars G.K. External beam radiotherapy dose response of prostate cancer. Int J Radiat Oncol Biol Phys. 39:1997;1011-1018.
11. Lawton C.A., Won M., Pilepich M.A., et al. Long-term treatment sequelae following external beam irradiation adenocarcinoma of the prostate Analysis of RTOG studies 7506 and 7706 . Int J Radiat Oncol Biol Phys. 21:1991;935-939.
12. Pilepich M.V., Caplan R., Byhardt R.W., et al. Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy Report of Radiation Therapy Oncology Group Protocol 85-31 . J Clin Oncol. 15:1997;1013-1021.
13. Pilepich M.V., Krall J.M., al-Sarraf M., et al. Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma A randomized comparative trial . Urology. 45:1995;616-623.
14. ICRU 50 Report 50. Prescribing, recording, and reporting photon beam therapy, Bethesda, MD: International Commission on Radiation Units and Measurement; 1993.
15. Roach M. Equations for predicting the pathologic stage of men with localized prostate cancer using the preoperative prostate specific antigen (PSA) and Gleason score. J Urol. 150:1993;1923-1924.
16. AJCC cancer staging manual. 4th ed. 1992;Lippincott-Raven, Philadelphia.
17. Roach M., Pickett B., Holland J., et al. The role of the urethrogram during simulation for localized prostate cancer. Int J Radiat Oncol Biol Phys. 25:1993;299-307.
18. Pilepich M.V., Asbell S.O., Krall J.M., et al. Correlation of radiotherapeutic parameters and treatment related morbidity. Analysis of RTOG Study 7706. Int J Radiat Oncol Biol Phy. 13:1987;1007-1012.
19. Pilepich M.V., Krall J.M., Sause W.T. Correlation of radiotherapeutic parameters and treatment related morbidity in carcinoma of the prostate-analysis of RTOG study 7506. Int J Radiot Oncol Biol Phys. 13:1987;1007-1012.
20. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 21:1991;109-122.
21. Agresti A. Categorical data analysis. 1990;John Wiley and Sons, New York.
22. Cox D.R. Regression and life tables. J Royal Stat Soc Series B. 34:1972;187-229.
23. Kuban D., EL-Mahdi A.M., Schellhammer P.F. Effect of local tumor control on distant metastasis and survival in prostatic adenocarcinoma. Urology. 30:1987;420-426.
24. Smit W.G., Helle P.A., Van Putten W.L.J. Late radiation damage in prostate cancer patients treated by high dose external radiotherapy in relation to rectal dose. Int J Radiat Oncol Biol Phys. 18:1990;23-29.
25. Hanks G.E. External-beam radiation therapy for clinically localized prostate cancer Patterns of care studies in the United States . NCI Monogr. 7:1988;75-84.
26. Ten Haken R.K., Perez-Tamayo C., Tersser R.J., et al. Boost treatment of the prostate using shaped, fixed fields. Int J Radiat Oncol Biol Phys. 16:1989;193-200.
27. Purdy J.A., Harms W.B., Michalski J., et al. Multi-institutional clinical trials 3-D conformal radiotherapy quality assurance. Guidelines in an NCI/RTOG study evaluating dose escalation in prostate cancer radiotherapy . Front Radiat Ther Oncol. 29:1996;255-263.
28. Hanlon L.A., Schultheiss T.E., Hunt M.A., et al. Chronic rectal bleeding after high-dose conformal treatment of prostate cancer warrants modification of existing morbidity scales. Int J Radiat Oncol Biol Phys. 38:1997;59-63.
29. Hanks G.E., Schultheiss T.E., Hunt M.A., et al. Factors influencing incidence of acute grade 2 morbidity in conformal and standard radiation treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 31:1995;25-29.
30. Zelefsky M.J., Fuks Z., Wolfe T., et al. Locally advanced prostatic cancer Long-term toxicity outcomes after three-dimensional conformal radiation therapy - a dose-escalation study . Radiology. 209:1998;169-174.
31. Nguyen L.N., Pollack A., Zagars G.K. Late effects after radiotherapy for prostate cancer in a randomized dose-response study Results of a self-assessment questionnaire . Urology. 51:1998;991-997.
32. Zelefsky M.J., Leibel S.A., Kutcher G.J., et al. The feasibility of dose escalation with three-dimensional conformal radiotherapy in patients with prostatic carcinoma. Cancer J Sci Am. 1:1995;142-150.
33. Lee W.R., Hanks G.E., Hanlon A.L., et al. Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer Further evidence for a significant dose effect . Int J Radiat Oncol Biol Phys. 35:1996;251-257.
34. Bosch W.D., Michalski J.M., Purdy J.A. An integrated image/clinical database for outcome studies in 3D conformal radiation therapy. (Abstr.) Int J Radiat Oncol Biol Phys. 41:1998;353.
35. Hanks G.E., Hanlon A.L., Schultheiss T.E., et al. Dose escalation with 3D conformal treatment Five year outcomes, treatment optimization, and future directions . Int J Radiat Oncol Biol Phys. 41:1998;501-510.
36. Zelefsky M.J., Leibel S.A., Gaudin P.B., et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys. 41:1998;491-500.